A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Cancer|Cancer|Solid Tumors
Interventions: DRUG: BIND-014
Sponsor: BIND Therapeutics